Contrarily, CD27 played a detrimental role in other cancers, including UVM and GBM, in which patients whose CD27 expression was high had a lower chance of survival than those whose CD27 mRNA levels were low (Figure 3A-D). This evidence concerns the gene CD27 and cancer.